Your browser doesn't support javascript.
Are patients with lung cystic fibrosis at increased risk of severe and fatal COVID-19? Interleukin 6 as a predictor of COVID-19 outcomes.
Marcinkiewicz, Janusz; Mazurek, Henryk; Majka, Grzegorz; Chain, Benjamin.
  • Marcinkiewicz J; Chair of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland. janusz.marcinkiewicz@uj.edu.pl
  • Mazurek H; Department of Pneumonology and Cystic Fibrosis, Institute of Tuberculosis and Lung Disorders, Rabka-Zdrój, Poland
  • Majka G; Chair of Immunology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland
  • Chain B; Division of Infection and Immunity, University College London, London, United Kingdom
Pol Arch Intern Med ; 130(10): 919-920, 2020 10 29.
Article in English | MEDLINE | ID: covidwho-814862
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Cystic Fibrosis / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Pol Arch Intern Med Year: 2020 Document Type: Article Affiliation country: Pamw.15630

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Coronavirus / Cystic Fibrosis / Pandemics Type of study: Prognostic study Limits: Humans Language: English Journal: Pol Arch Intern Med Year: 2020 Document Type: Article Affiliation country: Pamw.15630